CompanyGraph
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760 · SZSE · China
mindray.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $27.11B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 8.87: safe zone
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.07%Above 5Y avg (2.05%)
Annual Rate
CNY 3.12Paid semi-annual
Payout Ratio
71.6%Moderate
Payback Period
53.1 yr
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
182.53BCNY27.11B · vs all stocks (USD)
Trailing P/E
23.14xRevenue (TTM)
33.40BCNY4.96B · vs all stocks (USD)
Profit Margin
23.47%Beta
0.1780xvs all stocks
52-Week Change
-38.70%vs all stocks
Forward Annual Dividend Yield
2.07%vs all stocks
Market Capitalization
182.53BCNY27.11B · vs all stocks (USD)
Enterprise Value
168.41BCNY25.01B · vs all stocks (USD)
Trailing P/E
23.14xForward P/E
17.69xPEG Ratio
-2.03xPrice to Sales (TTM)
5.43xPrice to Book (MRQ)
4.52xEnterprise to Revenue
5.04xEnterprise to EBITDA
15.52xGross Margin
61.87%Profit Margin
23.47%Operating Margin
33.31%Return on Assets (TTM)
9.80%Return on Equity (TTM)
18.52%Revenue (TTM)
33.40BCNY4.96B · vs all stocks (USD)
Revenue per Share (TTM)
27.56CNYUpdated Aug 20, 2026Quarterly Revenue Growth
1.40%Gross Profit (TTM)
19.77BCNY2.94B · vs all stocks (USD)
EBITDA (TTM)
9.60BCNY1.43B · vs all stocks (USD)
Net Income (TTM)
7.84BCNY1.16B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-11.40%Operating Cash Flow (TTM)
10.03BCNY1.49B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
6.00BCNY890.62M · vs all stocks (USD)
Forward Annual Dividend Rate
3.12CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
2.07%vs all stocks
Trailing Annual Dividend Rate
2.91CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.93%vs all stocks
5-Year Average Dividend Yield
2.05%vs all stocks
Payout Ratio
71.59%Minority Interest (Equity)
4.92BCNYFY2025 · Dec 31, 2025Revenue
33.28BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
13.21BCNYFY2025 · Dec 31, 2025Gross Profit
20.07BCNYFY2025 · Dec 31, 2025Operating Income
9.94BCNY1.48B · vs all stocks (USD)
Pre-tax Income
9.67BCNYFY2025 · Dec 31, 2025Income Tax Expense
1.22BCNYFY2025 · Dec 31, 2025Net Income
8.45BCNYFY2025 · Dec 31, 2025EBIT
9.70BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
11.94BCNYFY2025 · Dec 31, 2025Research & Development
3.58BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.80BCNYFY2025 · Dec 31, 2025Other Operating Expenses
389.48MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
479.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
24.02MCNYFY2025 · Dec 31, 2025EPS (Basic)
6.71CNYFY2025 · Dec 31, 2025EPS (Diluted)
6.71CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.21BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.21BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
8.45BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-315.70MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
7.61BCNYFY2025 · Dec 31, 2025Free Cash Flow
5.61BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
17.62BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
8.45BCNYFY2025 · Dec 31, 2025Other Non-cash Items
161.78MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-345.55MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-655.43MCNYFY2025 · Dec 31, 2025Capital Expenditures
-2.00BCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.74BCNYFY2025 · Dec 31, 2025Sale of Investments
2.57BCNYFY2025 · Dec 31, 2025Other Investing Activity
1.66BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-509.40MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
4.71MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-7.27MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-5.61BCNYFY2025 · Dec 31, 2025Other Financing Charges
-978.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-6.60BCNYFY2025 · Dec 31, 2025Shares Outstanding
1.21BSharesUpdated Aug 20, 2026Float Shares
521.35MSharesUpdated Aug 20, 2026% Held by Insiders
55.96%vs all stocks
% Held by Institutions
13.62%vs all stocks
Total Cash (MRQ)
18.09BCNY2.69B · vs all stocks (USD)
Total Cash per Share (MRQ)
14.93CNYUpdated Aug 20, 2026Total Debt (MRQ)
342.96MCNY50.94M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0076xCurrent Ratio (MRQ)
2.39xBook Value per Share (MRQ)
33.10CNYUpdated Aug 20, 2026Total Assets
59.27BCNY8.80B · vs all stocks (USD)
Total Current Assets
27.41BCNYFY2025 · Dec 31, 2025Total Liabilities
16.26BCNYFY2025 · Dec 31, 2025Total Non-current Assets
31.86BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
4.66BCNYFY2025 · Dec 31, 2025Total Current Liabilities
11.60BCNYFY2025 · Dec 31, 2025Cash
17.63BCNYFY2025 · Dec 31, 2025Cash Equivalents
60.64MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
17.69BCNYFY2025 · Dec 31, 2025Other Short-term Investments
250.49MCNYFY2025 · Dec 31, 2025Accounts Receivable
3.41BCNYFY2025 · Dec 31, 2025Inventory
5.00BCNYFY2025 · Dec 31, 2025Accounts Payable
3.24BCNYFY2025 · Dec 31, 2025Short-term Debt
123.98MCNYFY2025 · Dec 31, 2025Other Current Liabilities
321.01MCNYFY2025 · Dec 31, 2025Long-term Debt
225.30MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.16BCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.21BCNYFY2025 · Dec 31, 2025Retained Earnings
30.14BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
43.01BCNY6.39B · vs all stocks (USD)
Treasury Stock
210.57MCNYFY2025 · Dec 31, 202552-Week Low
130.66CNYUpdated Aug 20, 202652-Week High
257.00CNYUpdated Aug 20, 202652-Week Change
-38.70%vs all stocks
Beta
0.1780xvs all stocks
50-Day MA
146.30CNYUpdated Aug 20, 2026200-Day MA
173.07CNYUpdated Aug 20, 2026Avg 10-Day Volume
9.42MSharesUpdated Aug 20, 2026Avg 30-Day Volume
10.98MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
6.47CNYUpdated Aug 20, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Diagnostic
Elevated Operating Margin With High Capex and Small D&A Gap
Margins read high with heavy capex and little depreciation charged against earnings.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 8.87: safe zoneNotable
Altman Z-Score: 8.87
High earnings qualityNotable
Earnings Quality Score: 0.68
High structural barrier to entryNotable
Barrier to Entry: 0.56
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $27.11B, higher than 95% of all stocks globallySignificant
Market cap (USD): 27,109,852,888.179Global P95: 25,614,208,870.135
Revenue is $4.96B, above the global median of $520.53MNotable
Revenue (USD): 4,960,121,860.178Global Median: 520,528,949.311
Levered free cash flow is $890.62M, above the global median of $16.24MNotable
Levered free cash flow (USD): 890,619,261.85Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Koninklijke Philips N.V.
Tier 1ProductionApproval-Gated PipelineRuleFlow
GE HealthCare Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Dexcom Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Roivant Sciences Ltd
Tier 1ProductionApproval-Gated PipelineRuleRisk
Moderna, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Biogen Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hansoh Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Insmed Inc.
Tier 1ProductionApproval-Gated PipelineRule
Incyte Corporation
Tier 1ProductionApproval-Gated PipelineRule
Celltrion Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Rightmove plc
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA Elevated
Birlasoft Ltd.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA Elevated
Want Want China Holdings Limited
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA Elevated